IDEXX Laboratories

YTD

ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacturing, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing industries. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other.

CEO

Michael Erickson

CEOMichael Erickson

Employees

11,000

Employees11,000

Headquarters

Westbrook, Maine

HeadquartersWestbrook, Maine

Founded

1983

Founded1983

Employees

11,000

Employees11,000

IDXX Key Statistics

Market cap

43.87B

Market cap43.87B

Price-Earnings ratio

38.36

Price-Earnings ratio38.36

Dividend yield

—

Dividend yield—

Average volume

552.96K

Average volume552.96K

High today

$557.66

High today$557.66

Low today

$545.62

Low today$545.62

Open price

$550.14

Open price$550.14

Volume

477.98K

Volume477.98K

52 Week high

$769.98

52 Week high$769.98

52 Week low

$518.55

52 Week low$518.55

Stock Snapshot

As of today, IDEXX Laboratories(IDXX) shares are valued at $556.93. The company's market cap stands at 43.87B, with a P/E ratio of 38.36.

On 2026-08-21, IDEXX Laboratories(IDXX) stock moved within a range of $545.62 to $557.66. With shares now at $556.93, the stock is trading +2.1% above its intraday low and -0.1% below the session's peak.

Trading volume for IDEXX Laboratories(IDXX) stock has reached 477.98K, versus its average volume of 552.96K.

The stock's 52-week range extends from a low of $518.55 to a high of $769.98.

IDXX News

Simply Wall St 2d

Will In-Clinic Cardiac Testing Expansion via Catalyst proBNP Test Change IDEXX Laboratories' Narrative

IDEXX Laboratories has launched the Catalyst proBNP Test, the first dual-species in-clinic NT-proBNP cardiac assay for cats and dogs, extending its connected di...

Simply Wall St 3d

IDEXX Laboratories Could Be 22% Undervalued As New Cardiac Test Expands Its Reach

Advertisement New cardiac test launch puts IDEXX Laboratories stock in focus IDEXX Laboratories (IDXX) has drawn fresh investor attention after announcing the...

Analyst ratings

56%

of 16 ratings

Buy

56.3%

Hold

37.5%

Sell

6.3%

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.